The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gossamer Bio Inc shares valued at $50,016 were purchased by Milligan Sandra on Aug 19 ’25. At $1.92 per share, Milligan Sandra acquired 26,050 shares. The insider’s holdings grew to 58,050 shares worth approximately $0.17 million following the completion of this transaction.
As published in a research note from UBS on September 10, 2025, Gossamer Bio Inc [GOSS] has been rated up from a Neutral to a Buy and the price target has been revised to $9. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid July. As of June 25, 2024, Oppenheimer has initiated its “an Outperform” rating for GOSS.
Analyzing GOSS Stock Performance
On last trading session, Gossamer Bio Inc [NASDAQ: GOSS] plunged -2.92% to $2.99. The stock’s lowest price that day was $2.975, but it reached a high of $3.175 in the same session. Over the course of the year, Gossamer Bio Inc shares have jumped approximately 184.76%. Shares of the company reached a 52-week high of $3.60 on 09/12/25 and a 52-week low of $0.76 on 04/09/25.
Support And Resistance Levels for Gossamer Bio Inc (GOSS)
According to the 24-hour chart, there is a support level at 2.92, which, if violated, would cause prices to drop to 2.85. In the upper region, resistance lies at 3.12. The next price resistance is at 3.25. RSI (Relative Strength Index) is 57.12 on the 14-day chart, showing neutral technical sentiment.
Is Gossamer Bio Inc subject to short interest?
Stocks of Gossamer Bio Inc saw a sharp rise in short interest on 2025-08-29 jumping by 3.3 million shares to 22.05 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 18.75 million shares. A jump of 14.98% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.02 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.02.
Which companies own the most shares of Gossamer Bio Inc (GOSS)?
In terms of Gossamer Bio Inc share price expectations, FactSet research, analysts set an average price target of 9 in the next 12 months, up nearly 192.21% from the previous closing price of $3.08. Analysts anticipate Gossamer Bio Inc stock to reach 9 by 2025, with the lowest price target being 9. In spite of this, 10 analysts ranked Gossamer Bio Inc stock as Buy at the end of 2025. On July 27, 2023, UBS assigned a price target of “a Neutral” to the stock and downgraded coverage with a $1.25.
